Loading…

Cost‐effectiveness of inpatient and intensive outpatient treatment of rheumatoid arthritis. A randomized, controlled trial

Women with active rheumatoid arthritis who were judged to be in need of hospitalization were assigned at random to receive inpatient therapy (n = 35) or intensive outpatient therapy (n = 36). All relevant costs of treatment were measured. At 19 weeks, clinical outcomes, as summarized in a pooled ind...

Full description

Saved in:

Bibliographic Details
Published in:	Arthritis and rheumatism 1989-12, Vol.32 (12), p.1505-1514
Main Authors:	Helewa, Antoine, Bombardier, Claire, Goldsmith, Charles H., Menchions, Bruce, Smythe, Hugh A.
Format:	Article
Language:	English
Subjects:	Adolescent Adult Aged Ambulatory Care - economics Analysis of Variance Anti-Inflammatory Agents - therapeutic use Arthritis, Rheumatoid - blood Arthritis, Rheumatoid - drug therapy Arthritis, Rheumatoid - physiopathology Biological and medical sciences Blood Sedimentation Cost-Benefit Analysis Diseases of the osteoarticular system Female Hospitalization - economics Humans Inflammatory joint diseases Joints - physiopathology Medical sciences Middle Aged Outcome and Process Assessment (Health Care) Randomized Controlled Trials as Topic
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by	cdi_FETCH-LOGICAL-c4093-7a4282a0de0b9dde6c005eefc210dfa76db893a155dd9a70589184c19897b6703
cites	cdi_FETCH-LOGICAL-c4093-7a4282a0de0b9dde6c005eefc210dfa76db893a155dd9a70589184c19897b6703
container_end_page	1514
container_issue	12
container_start_page	1505
container_title	Arthritis and rheumatism
container_volume	32
creator	Helewa, Antoine Bombardier, Claire Goldsmith, Charles H. Menchions, Bruce Smythe, Hugh A.
description	Women with active rheumatoid arthritis who were judged to be in need of hospitalization were assigned at random to receive inpatient therapy (n = 35) or intensive outpatient therapy (n = 36). All relevant costs of treatment were measured. At 19 weeks, clinical outcomes, as summarized in a pooled index, were significantly better in the inpatient group (pooled index units: inpatient 0.72, outpatient 0.25; F[1,69] = 10.9, P = 0.002). Inpatient therapy produced a sustained threefold increase in efficacy, at a 2.5‐fold increase in cost to society.
doi_str_mv	10.1002/anr.1780321203
format	article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79380655</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79380655</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4093-7a4282a0de0b9dde6c005eefc210dfa76db893a155dd9a70589184c19897b6703</originalsourceid><addsrcrecordid>eNqFkM1u1DAURi0Eaoe2W3ZIWaCuyHBtj-N4ORrxU6kSEirr6I59oxol8dR2qIpY9BH6jDwJrmYo7FjZV9_5rq3D2CsOSw4g3uEUl1y3IAUXIJ-xBVfC1MAlf84WALCqpTL8mL1M6VsZhVTyiB0JxYWRzYL93ISUf90_UN-Tzf47TZRSFfrKTzvMnqZc4eTKlGlKJa7CnP8EORLm8fFW-HhN84g5eFdhzNfRZ5-W1bqKpR5G_4Pc28qGKccwDORK1-Nwyl70OCQ6O5wn7OuH91ebT_Xl548Xm_VlbVdgZK1xJVqB4Ai2xjlqLIAi6q3g4HrUjdu2RiJXyjmDGlRreLuy3LRGbxsN8oSd7_fuYriZKeVu9MnSMOBEYU6dNrKFRqkCLvegjSGlSH23i37EeNdx6B51d0V391d3Kbw-bJ63I7kn_OC35G8OOSaLQ19sWJ-esKZpAbQumNljt36gu_882q2_XP3zhd8MIJwP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79380655</pqid></control><display><type>article</type><title>Cost‐effectiveness of inpatient and intensive outpatient treatment of rheumatoid arthritis. A randomized, controlled trial</title><source>Wiley-Blackwell Journals (Backfile Content)</source><creator>Helewa, Antoine ; Bombardier, Claire ; Goldsmith, Charles H. ; Menchions, Bruce ; Smythe, Hugh A.</creator><creatorcontrib>Helewa, Antoine ; Bombardier, Claire ; Goldsmith, Charles H. ; Menchions, Bruce ; Smythe, Hugh A.</creatorcontrib><description>Women with active rheumatoid arthritis who were judged to be in need of hospitalization were assigned at random to receive inpatient therapy (n = 35) or intensive outpatient therapy (n = 36). All relevant costs of treatment were measured. At 19 weeks, clinical outcomes, as summarized in a pooled index, were significantly better in the inpatient group (pooled index units: inpatient 0.72, outpatient 0.25; F[1,69] = 10.9, P = 0.002). Inpatient therapy produced a sustained threefold increase in efficacy, at a 2.5‐fold increase in cost to society.</description><identifier>ISSN: 0004-3591</identifier><identifier>EISSN: 1529-0131</identifier><identifier>DOI: 10.1002/anr.1780321203</identifier><identifier>PMID: 2512936</identifier><identifier>CODEN: ARHEAW</identifier><language>eng</language><publisher>New York: John Wiley & Sons, Inc</publisher><subject>Adolescent ; Adult ; Aged ; Ambulatory Care - economics ; Analysis of Variance ; Anti-Inflammatory Agents - therapeutic use ; Arthritis, Rheumatoid - blood ; Arthritis, Rheumatoid - drug therapy ; Arthritis, Rheumatoid - physiopathology ; Biological and medical sciences ; Blood Sedimentation ; Cost-Benefit Analysis ; Diseases of the osteoarticular system ; Female ; Hospitalization - economics ; Humans ; Inflammatory joint diseases ; Joints - physiopathology ; Medical sciences ; Middle Aged ; Outcome and Process Assessment (Health Care) ; Randomized Controlled Trials as Topic</subject><ispartof>Arthritis and rheumatism, 1989-12, Vol.32 (12), p.1505-1514</ispartof><rights>Copyright © 1989 American College of Rheumatology</rights><rights>1990 INIST-CNRS</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4093-7a4282a0de0b9dde6c005eefc210dfa76db893a155dd9a70589184c19897b6703</citedby><cites>FETCH-LOGICAL-c4093-7a4282a0de0b9dde6c005eefc210dfa76db893a155dd9a70589184c19897b6703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fanr.1780321203$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fanr.1780321203$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1415,27923,27924,46048,46472</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=6680077$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2512936$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Helewa, Antoine</creatorcontrib><creatorcontrib>Bombardier, Claire</creatorcontrib><creatorcontrib>Goldsmith, Charles H.</creatorcontrib><creatorcontrib>Menchions, Bruce</creatorcontrib><creatorcontrib>Smythe, Hugh A.</creatorcontrib><title>Cost‐effectiveness of inpatient and intensive outpatient treatment of rheumatoid arthritis. A randomized, controlled trial</title><title>Arthritis and rheumatism</title><addtitle>Arthritis Rheum</addtitle><description>Women with active rheumatoid arthritis who were judged to be in need of hospitalization were assigned at random to receive inpatient therapy (n = 35) or intensive outpatient therapy (n = 36). All relevant costs of treatment were measured. At 19 weeks, clinical outcomes, as summarized in a pooled index, were significantly better in the inpatient group (pooled index units: inpatient 0.72, outpatient 0.25; F[1,69] = 10.9, P = 0.002). Inpatient therapy produced a sustained threefold increase in efficacy, at a 2.5‐fold increase in cost to society.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Ambulatory Care - economics</subject><subject>Analysis of Variance</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Arthritis, Rheumatoid - blood</subject><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Arthritis, Rheumatoid - physiopathology</subject><subject>Biological and medical sciences</subject><subject>Blood Sedimentation</subject><subject>Cost-Benefit Analysis</subject><subject>Diseases of the osteoarticular system</subject><subject>Female</subject><subject>Hospitalization - economics</subject><subject>Humans</subject><subject>Inflammatory joint diseases</subject><subject>Joints - physiopathology</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Outcome and Process Assessment (Health Care)</subject><subject>Randomized Controlled Trials as Topic</subject><issn>0004-3591</issn><issn>1529-0131</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><recordid>eNqFkM1u1DAURi0Eaoe2W3ZIWaCuyHBtj-N4ORrxU6kSEirr6I59oxol8dR2qIpY9BH6jDwJrmYo7FjZV9_5rq3D2CsOSw4g3uEUl1y3IAUXIJ-xBVfC1MAlf84WALCqpTL8mL1M6VsZhVTyiB0JxYWRzYL93ISUf90_UN-Tzf47TZRSFfrKTzvMnqZc4eTKlGlKJa7CnP8EORLm8fFW-HhN84g5eFdhzNfRZ5-W1bqKpR5G_4Pc28qGKccwDORK1-Nwyl70OCQ6O5wn7OuH91ebT_Xl548Xm_VlbVdgZK1xJVqB4Ai2xjlqLIAi6q3g4HrUjdu2RiJXyjmDGlRreLuy3LRGbxsN8oSd7_fuYriZKeVu9MnSMOBEYU6dNrKFRqkCLvegjSGlSH23i37EeNdx6B51d0V391d3Kbw-bJ63I7kn_OC35G8OOSaLQ19sWJ-esKZpAbQumNljt36gu_882q2_XP3zhd8MIJwP</recordid><startdate>198912</startdate><enddate>198912</enddate><creator>Helewa, Antoine</creator><creator>Bombardier, Claire</creator><creator>Goldsmith, Charles H.</creator><creator>Menchions, Bruce</creator><creator>Smythe, Hugh A.</creator><general>John Wiley & Sons, Inc</general><general>Wiley</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198912</creationdate><title>Cost‐effectiveness of inpatient and intensive outpatient treatment of rheumatoid arthritis. A randomized, controlled trial</title><author>Helewa, Antoine ; Bombardier, Claire ; Goldsmith, Charles H. ; Menchions, Bruce ; Smythe, Hugh A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4093-7a4282a0de0b9dde6c005eefc210dfa76db893a155dd9a70589184c19897b6703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Ambulatory Care - economics</topic><topic>Analysis of Variance</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Arthritis, Rheumatoid - blood</topic><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Arthritis, Rheumatoid - physiopathology</topic><topic>Biological and medical sciences</topic><topic>Blood Sedimentation</topic><topic>Cost-Benefit Analysis</topic><topic>Diseases of the osteoarticular system</topic><topic>Female</topic><topic>Hospitalization - economics</topic><topic>Humans</topic><topic>Inflammatory joint diseases</topic><topic>Joints - physiopathology</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Outcome and Process Assessment (Health Care)</topic><topic>Randomized Controlled Trials as Topic</topic><toplevel>online_resources</toplevel><creatorcontrib>Helewa, Antoine</creatorcontrib><creatorcontrib>Bombardier, Claire</creatorcontrib><creatorcontrib>Goldsmith, Charles H.</creatorcontrib><creatorcontrib>Menchions, Bruce</creatorcontrib><creatorcontrib>Smythe, Hugh A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Arthritis and rheumatism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Helewa, Antoine</au><au>Bombardier, Claire</au><au>Goldsmith, Charles H.</au><au>Menchions, Bruce</au><au>Smythe, Hugh A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cost‐effectiveness of inpatient and intensive outpatient treatment of rheumatoid arthritis. A randomized, controlled trial</atitle><jtitle>Arthritis and rheumatism</jtitle><addtitle>Arthritis Rheum</addtitle><date>1989-12</date><risdate>1989</risdate><volume>32</volume><issue>12</issue><spage>1505</spage><epage>1514</epage><pages>1505-1514</pages><issn>0004-3591</issn><eissn>1529-0131</eissn><coden>ARHEAW</coden><abstract>Women with active rheumatoid arthritis who were judged to be in need of hospitalization were assigned at random to receive inpatient therapy (n = 35) or intensive outpatient therapy (n = 36). All relevant costs of treatment were measured. At 19 weeks, clinical outcomes, as summarized in a pooled index, were significantly better in the inpatient group (pooled index units: inpatient 0.72, outpatient 0.25; F[1,69] = 10.9, P = 0.002). Inpatient therapy produced a sustained threefold increase in efficacy, at a 2.5‐fold increase in cost to society.</abstract><cop>New York</cop><pub>John Wiley & Sons, Inc</pub><pmid>2512936</pmid><doi>10.1002/anr.1780321203</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0004-3591
ispartof	Arthritis and rheumatism, 1989-12, Vol.32 (12), p.1505-1514
issn	0004-3591 1529-0131
language	eng
recordid	cdi_proquest_miscellaneous_79380655
source	Wiley-Blackwell Journals (Backfile Content)
subjects	Adolescent Adult Aged Ambulatory Care - economics Analysis of Variance Anti-Inflammatory Agents - therapeutic use Arthritis, Rheumatoid - blood Arthritis, Rheumatoid - drug therapy Arthritis, Rheumatoid - physiopathology Biological and medical sciences Blood Sedimentation Cost-Benefit Analysis Diseases of the osteoarticular system Female Hospitalization - economics Humans Inflammatory joint diseases Joints - physiopathology Medical sciences Middle Aged Outcome and Process Assessment (Health Care) Randomized Controlled Trials as Topic
title	Cost‐effectiveness of inpatient and intensive outpatient treatment of rheumatoid arthritis. A randomized, controlled trial
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T13%3A43%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cost%E2%80%90effectiveness%20of%20inpatient%20and%20intensive%20outpatient%20treatment%20of%20rheumatoid%20arthritis.%20A%20randomized,%20controlled%20trial&rft.jtitle=Arthritis%20and%20rheumatism&rft.au=Helewa,%20Antoine&rft.date=1989-12&rft.volume=32&rft.issue=12&rft.spage=1505&rft.epage=1514&rft.pages=1505-1514&rft.issn=0004-3591&rft.eissn=1529-0131&rft.coden=ARHEAW&rft_id=info:doi/10.1002/anr.1780321203&rft_dat=%3Cproquest_cross%3E79380655%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4093-7a4282a0de0b9dde6c005eefc210dfa76db893a155dd9a70589184c19897b6703%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=79380655&rft_id=info:pmid/2512936&rfr_iscdi=true